» Articles » PMID: 33668239

Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia Without Invasive Carcinoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Mar 6
PMID 33668239
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic ductal adenocarcinoma (PDAC) arises from precursor lesions, such as pancreatic intra-epithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN). The prognosis of high-grade precancerous lesions, including high-grade PanIN and high-grade IPMN, without invasive carcinoma is good, despite the overall poor prognosis of PDAC. High-grade PanIN, as a lesion preceding invasive PDAC, is therefore a primary target for intervention. However, detection of localized high-grade PanIN is difficult when using standard radiological approaches. Therefore, most studies of high-grade PanIN have been conducted using specimens that harbor invasive PDAC. Recently, imaging characteristics of high-grade PanIN have been revealed. Obstruction of the pancreatic duct due to high-grade PanIN may induce a loss of acinar cells replaced by fibrosis and lobular parenchymal atrophy. These changes and additional inflammation around the branch pancreatic ducts (BPDs) result in main pancreatic duct (MPD) stenosis, dilation, retention cysts (BPD dilation), focal pancreatic parenchymal atrophy, and/or hypoechoic changes around the MPD. These indirect imaging findings have become important clues for localized, high-grade PanIN detection. To obtain pre-operative histopathological confirmation of suspected cases, serial pancreatic-juice aspiration cytologic examination is effective. In this review, we outline current knowledge on imaging characteristics of high-grade PanIN.

Citing Articles

Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study.

Miki M, Masuda A, Takenaka M, Shiomi H, Iemoto T, Tsumura H J Gastroenterol. 2024; 59(12):1133-1142.

PMID: 39283502 PMC: 11541273. DOI: 10.1007/s00535-024-02149-0.


Potential of Carbohydrate Antigen 19-9 and Serum Apolipoprotein A2-Isoforms in the Diagnosis of Stage 0 and IA Pancreatic Cancer.

Hanada K, Shimizu A, Tsushima K, Kobayashi M Diagnostics (Basel). 2024; 14(17).

PMID: 39272705 PMC: 11394136. DOI: 10.3390/diagnostics14171920.


Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer.

Mustafa M, Abbas K, Alam M, Habib S, Zulfareen , Hasan G Front Oncol. 2024; 14:1427802.

PMID: 39087024 PMC: 11288929. DOI: 10.3389/fonc.2024.1427802.


Early diagnosis of pancreatic cancer: Shedding light on an unresolved challenge.

Lindner C World J Clin Cases. 2024; 12(14):2463-2465.

PMID: 38765749 PMC: 11099421. DOI: 10.12998/wjcc.v12.i14.2463.


CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.

Kim M, Kim J, Jeon S, Kang H PLoS One. 2024; 19(4):e0298278.

PMID: 38683769 PMC: 11057734. DOI: 10.1371/journal.pone.0298278.


References
1.
Kobayashi N, Sugimori K, Shimamura T, Hosono K, Watanabe S, Kato S . Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012; 12(2):141-5. DOI: 10.1016/j.pan.2011.12.008. View

2.
Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M . Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126(2):451-9. DOI: 10.1053/j.gastro.2003.11.010. View

3.
Choi J, Kim M, Lee J, Lim J, Chung J, Kim K . Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathologic correlation. AJR Am J Roentgenol. 2009; 193(1):136-42. DOI: 10.2214/AJR.08.1309. View

4.
Yamao K, Takenaka M, Ishikawa R, Okamoto A, Yamazaki T, Nakai A . Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients. Diagnostics (Basel). 2020; 10(7). PMC: 7400308. DOI: 10.3390/diagnostics10070445. View

5.
Singhi A, Koay E, Chari S, Maitra A . Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019; 156(7):2024-2040. PMC: 6486851. DOI: 10.1053/j.gastro.2019.01.259. View